A Leader in First-in-Patient Studies
State-of-the-Art Research Unit
Contact us now
MHRA Phase 1 Accredited
Contact us now
Intelligent Recruitment Strategies
to Facilitate Patient Selections
Please call our recruitment manager for direct access to feasibility
Contact us now
Previous slide
Next slide

A LEADER IN EARLY PHASE CLINICAL TRIALS IN MANCHESTER

Phase 1 Clinical Trials

The MEU is a UK leader in Early Phase clinical trials in Manchester. We have considerable expertise in SAD and MAD trials. The emergence of hybrid designs, including patient cohorts, has allowed the MEU to provide a complete solution for clients seeking a single site solution for their Early Phase programme.

Therapeutic Areas

The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase I studies in many other therapeutic areas.

Facilities

The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase I studies in many other therapeutic areas.

Recruitment

The MEU is well-equipped to undertake large single centre early phase healthy volunteer clinical trials and specialist respiratory trials including Asthma, COPD, Cystic Fibrosis, Allergy, Dermatology, Inflammatory, Cardiovascular and Diabetes. Our ever-expansive portfolio facilitates the MEU to undertake Phase I studies in many other therapeutic areas.

Medical Propellants

The MEU is now at the forefront of testing new climate-friendly inhalers to ensure they are safe and effective for large populations worldwide and to support the transition towards low GWP propellants in devices used for inhaled drug delivery.

MEASURING EXCELLENCE WITHIN AN EARLY PHASE TRIALS UNIT

Phase I Accreditation

The MEU is an MHRA Phase I accredited unit and has been part of the scheme since its inception. This ensures that our studies are conducted to the highest standards in terms of both safety and quality.

MEU have held MHRA Phase I accreditation since July 2009 with the latest inspection being 2018.

Inspection results

Our last five inspections, shown below, show 11 Years of No Criticals and, No Majors findings:

An MEU doctor discusses careers at clinical research unit

A leader in Early Phase clinical trials for over twenty years

Latest News